Screener
Agios Pharmaceuticals AGIO Other Non-Current Assets
Other Non-Current Assets at other companies
Other financials
Where this comes from
Reported directly by Agios Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:LessorOperatingLeasePaymentsToBeReceivedRemainderOfFiscalYear.
The source filing: Agios Pharmaceuticals’s 10-Q, filed July 30, 2026.
- Filed
- Jul 30, 2026, 9:56 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001439222-26-000118
FAQ
- What is Agios Pharmaceuticals's other non-current assets?
- Agios Pharmaceuticals (AGIO) reported other non-current assets of $465K in Q2 2026.
- How has Agios Pharmaceuticals's other non-current assets changed year-over-year?
- Agios Pharmaceuticals's other non-current assets increased by 1400.0% year-over-year, from $31K to $465K.
- What is the long-term trend for Agios Pharmaceuticals's other non-current assets?
- Over 5 years (2020 to 2025), Agios Pharmaceuticals's other non-current assets has grown at a 28.4% compound annual growth rate (CAGR), from $1.13M to $3.93M.
- What does other non-current assets mean?
- Long-term assets not classified in specific categories — a catch-all for miscellaneous non-current assets.
Ask your AI about Agios Pharmaceuticals's other non-current assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude